博士生导师
硕士生导师
教师拼音名称：lidongxiang
电子邮箱：
学历：博士研究生
学位：理学博士
毕业院校：山东大学
通讯/办公地址：
邮编：
邮箱：
移动电话：
最后更新时间：..
>>
>>
关键字：DRUG-DELIVERY; NANOPARTICLES; STRATEGIES; APOPTOSIS; RELEASE; DOXORUBICIN; RECEPTOR; SYSTEMS; DESIGN; ASSAY
摘要：A series of amphiphilic peptides with sequence of Ac-RGDGPLGLAGI(3)GRn-NH2 (n=4, 6, 8) have been designed for the aim of selective cancer-killing. These molecules have four functional segments, the integrin-binding segment of RGD, the enzyme-cleavable segment of PLGLA, the hydrophobic segment of I-3, and the cell membrane-penetrating segment of octa-arginine. Among them, the peptide with n=8 (RR-22) turns out to be a 'smart' molecule with high efficiency in killing cancer cells and negligible cytotoxicity to normal cells. The concentration causing 50% cancer cell growth inhibition (IC50) is 50 mu M for HeLa, 41 mu M for Hpeg2, and 44 mu M for A549, respectively. The high cancer-killing selectivity is ascribed to the dual cancer-targeting function, that is, the specific recognition and binding of RGD segment to cancer membranes and the cleavage of PLGLA segment by the cancer-overexpressed matrix metalloproteinase-7 (MMP7). This study illustrates an effective strategy for designing smart therapeutic molecules with both selectivity and targeting ability.
卷号：586
是否译文：否
